A Future-forward Influenza Immunization Model of Care for High-risk Patients in Pharmacies: A Canadian Consensus

Overview

Journal Can Pharm J (Ott)

Specialty Pharmacology

Date 2024 Sep 23

PMID 39310803

Authors

Aaron Sihota

Cameron Bonell

Brittany Buffone

Sherilyn K D Houle

Michael Kani

Josh Kim

Erica MacLean

Anas Nseir

Pavithra Ravinatarajan

Francis Richard

Tiana Tilli

Carolyn Whiskin

Victor Wong

Paul Roumeliotis

Affiliations

Soon will be listed here.

References

Law M, Heard D, Fisher J, Douillard J, Muzika G, Sketris I . The geographic accessibility of pharmacies in Nova Scotia. Can Pharm J (Ott). 2013; 146(1):39-46. PMC: 3676246. DOI: 10.1177/1715163512473062. View

Marra F, Kaczorowski J, Gastonguay L, Marra C, Lynd L, Kendall P . Pharmacy-based Immunization in Rural Communities Strategy (PhICS): A community cluster-randomized trial. Can Pharm J (Ott). 2014; 147(1):33-44. PMC: 3908619. DOI: 10.1177/1715163513514020. View

Martin E . Improving influenza vaccination rates for pediatric asthmatics by use of an asthma educational tool and a patient electronic care system. Clin Pediatr (Phila). 2008; 47(6):588-92. DOI: 10.1177/0009922808314902. View

Papastergiou J, Folkins C, Li W, Zervas J . Community pharmacist-administered influenza immunization improves patient access to vaccination. Can Pharm J (Ott). 2014; 147(6):359-65. PMC: 4213255. DOI: 10.1177/1715163514552557. View

Buchan S, Rosella L, Finkelstein M, Juurlink D, Isenor J, Marra F . Impact of pharmacist administration of influenza vaccines on uptake in Canada. CMAJ. 2016; 189(4):E146-E152. PMC: 5266568. DOI: 10.1503/cmaj.151027. View

Isler O, Isler B, Kopsacheilis O, Ferguson E . Limits of the social-benefit motive among high-risk patients: a field experiment on influenza vaccination behaviour. BMC Public Health. 2020; 20(1):240. PMC: 7027065. DOI: 10.1186/s12889-020-8246-3. View

Isenor J, Alia T, Killen J, Billard B, Halperin B, Slayter K . Impact of pharmacists as immunizers on influenza vaccination coverage in Nova Scotia, Canada. Hum Vaccin Immunother. 2016; 12(5):1225-8. PMC: 4963057. DOI: 10.1080/21645515.2015.1127490. View

Spaulding S, Kugler J . Influenza immunization: the impact of notifying patients of high-risk status. J Fam Pract. 1991; 33(5):495-8. View

Kumar S, Shah Z, Garfield S . Causes of Vaccine Hesitancy in Adults for the Influenza and COVID-19 Vaccines: A Systematic Literature Review. Vaccines (Basel). 2022; 10(9). PMC: 9503596. DOI: 10.3390/vaccines10091518. View

10.

Shen S, Dubey V . Addressing vaccine hesitancy: Clinical guidance for primary care physicians working with parents. Can Fam Physician. 2019; 65(3):175-181. PMC: 6515949. View

11.

Gaglani M, Riggs M, Kamenicky C, Glezen W . A computerized reminder strategy is effective for annual influenza immunization of children with asthma or reactive airway disease. Pediatr Infect Dis J. 2001; 20(12):1155-60. DOI: 10.1097/00006454-200112000-00012. View

12.

Sambamoorthi U, Findley P . Who are the elderly who never receive influenza immunization?. Prev Med. 2004; 40(4):469-78. DOI: 10.1016/j.ypmed.2004.07.017. View

13.

Moran W, Nelson K, WOFFORD J, Velez R, Case L . Increasing influenza immunization among high-risk patients: education or financial incentive?. Am J Med. 1996; 101(6):612-20. DOI: 10.1016/S0002-9343(96)00327-0. View

14.

Li L, Wood C, Kostkova P . Vaccine hesitancy and behavior change theory-based social media interventions: a systematic review. Transl Behav Med. 2021; 12(2):243-272. PMC: 8848992. DOI: 10.1093/tbm/ibab148. View

15.

Paget J, Caini S, Riccio M, van Waarden W, Meijer A . Has influenza B/Yamagata become extinct and what implications might this have for quadrivalent influenza vaccines?. Euro Surveill. 2022; 27(39). PMC: 9524051. DOI: 10.2807/1560-7917.ES.2022.27.39.2200753. View